CH641493A5 - Verfahren zur bestimmung von gram-negativen bakterien. - Google Patents
Verfahren zur bestimmung von gram-negativen bakterien. Download PDFInfo
- Publication number
- CH641493A5 CH641493A5 CH377279A CH377279A CH641493A5 CH 641493 A5 CH641493 A5 CH 641493A5 CH 377279 A CH377279 A CH 377279A CH 377279 A CH377279 A CH 377279A CH 641493 A5 CH641493 A5 CH 641493A5
- Authority
- CH
- Switzerland
- Prior art keywords
- microorganisms
- liquid
- liquid phase
- pyrogen
- negative bacteria
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims description 20
- 241000894006 Bacteria Species 0.000 title claims description 17
- 244000005700 microbiome Species 0.000 claims description 23
- 239000007788 liquid Substances 0.000 claims description 20
- 239000007791 liquid phase Substances 0.000 claims description 13
- 239000004094 surface-active agent Substances 0.000 claims description 12
- 239000006166 lysate Substances 0.000 claims description 11
- 241000239220 Limulus polyphemus Species 0.000 claims description 9
- 210000004369 blood Anatomy 0.000 claims description 6
- 239000008280 blood Substances 0.000 claims description 6
- 238000005119 centrifugation Methods 0.000 claims description 6
- 238000004062 sedimentation Methods 0.000 claims description 6
- 238000001914 filtration Methods 0.000 claims description 5
- 239000002510 pyrogen Substances 0.000 claims description 3
- 238000000926 separation method Methods 0.000 claims description 3
- 238000005406 washing Methods 0.000 claims description 2
- 239000003085 diluting agent Substances 0.000 claims 1
- 238000012360 testing method Methods 0.000 description 12
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 10
- 239000002158 endotoxin Substances 0.000 description 10
- 230000003287 optical effect Effects 0.000 description 8
- 239000000523 sample Substances 0.000 description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- 239000013060 biological fluid Substances 0.000 description 7
- 210000004027 cell Anatomy 0.000 description 7
- 239000000243 solution Substances 0.000 description 7
- 239000002244 precipitate Substances 0.000 description 5
- 239000006228 supernatant Substances 0.000 description 5
- 241000588724 Escherichia coli Species 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- 238000011534 incubation Methods 0.000 description 4
- 239000000725 suspension Substances 0.000 description 4
- 239000007864 aqueous solution Substances 0.000 description 3
- 239000011148 porous material Substances 0.000 description 3
- 239000011780 sodium chloride Substances 0.000 description 3
- 208000031729 Bacteremia Diseases 0.000 description 2
- 239000002028 Biomass Substances 0.000 description 2
- 208000035473 Communicable disease Diseases 0.000 description 2
- 239000013504 Triton X-100 Substances 0.000 description 2
- 229920004890 Triton X-100 Polymers 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 210000000601 blood cell Anatomy 0.000 description 2
- 238000011088 calibration curve Methods 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- HDFXRQJQZBPDLF-UHFFFAOYSA-L disodium hydrogen carbonate Chemical compound [Na+].[Na+].OC([O-])=O.OC([O-])=O HDFXRQJQZBPDLF-UHFFFAOYSA-L 0.000 description 2
- 238000004090 dissolution Methods 0.000 description 2
- 230000007613 environmental effect Effects 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 238000012454 limulus amebocyte lysate test Methods 0.000 description 2
- 230000002934 lysing effect Effects 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- 239000012086 standard solution Substances 0.000 description 2
- 206010003445 Ascites Diseases 0.000 description 1
- 241000606125 Bacteroides Species 0.000 description 1
- 241000606124 Bacteroides fragilis Species 0.000 description 1
- 241000588722 Escherichia Species 0.000 description 1
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 1
- 241000588748 Klebsiella Species 0.000 description 1
- 241000588747 Klebsiella pneumoniae Species 0.000 description 1
- 241000239218 Limulus Species 0.000 description 1
- 241001302191 Polyphemus Species 0.000 description 1
- GOOHAUXETOMSMM-UHFFFAOYSA-N Propylene oxide Chemical compound CC1CO1 GOOHAUXETOMSMM-UHFFFAOYSA-N 0.000 description 1
- 206010040047 Sepsis Diseases 0.000 description 1
- 210000000683 abdominal cavity Anatomy 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- 239000003708 ampul Substances 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 239000012472 biological sample Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000009640 blood culture Methods 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 210000001175 cerebrospinal fluid Anatomy 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 230000005484 gravity Effects 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 229920006008 lipopolysaccharide Polymers 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- UYDLBVPAAFVANX-UHFFFAOYSA-N octylphenoxy polyethoxyethanol Chemical compound CC(C)(C)CC(C)(C)C1=CC=C(OCCOCCOCCOCCO)C=C1 UYDLBVPAAFVANX-UHFFFAOYSA-N 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 230000002980 postoperative effect Effects 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 230000001698 pyrogenic effect Effects 0.000 description 1
- 239000013535 sea water Substances 0.000 description 1
- 239000013049 sediment Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 210000000278 spinal cord Anatomy 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 239000011550 stock solution Substances 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 238000003828 vacuum filtration Methods 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 239000008207 working material Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
- C12Q1/04—Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Analytical Chemistry (AREA)
- Toxicology (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US89829178A | 1978-04-20 | 1978-04-20 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CH641493A5 true CH641493A5 (de) | 1984-02-29 |
Family
ID=25409227
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CH377279A CH641493A5 (de) | 1978-04-20 | 1979-04-20 | Verfahren zur bestimmung von gram-negativen bakterien. |
Country Status (9)
| Country | Link |
|---|---|
| JP (1) | JPS54149699A (fr) |
| BE (1) | BE875716A (fr) |
| CA (1) | CA1114271A (fr) |
| CH (1) | CH641493A5 (fr) |
| DE (1) | DE2915569A1 (fr) |
| FR (1) | FR2423784A1 (fr) |
| GB (1) | GB2019563B (fr) |
| IT (1) | IT1119718B (fr) |
| NL (1) | NL7902983A (fr) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4322217A (en) | 1980-06-27 | 1982-03-30 | Mallinckrodt, Inc. | Process for preparing Limulus lysate |
| US5594113A (en) * | 1988-06-23 | 1997-01-14 | Associates Of Cape Cod, Inc. | Endotoxin binding and neutralizing protein and uses thereof |
| EP3192876A1 (fr) * | 2007-10-10 | 2017-07-19 | Pocared Diagnostics Ltd. | Système permettant d'effectuer l'identification de bactéries dans l'urine |
| US8519358B2 (en) | 2008-02-05 | 2013-08-27 | Pocared Diagnostics Ltd. | System for conducting the identification of bacteria in biological samples |
| US10288632B2 (en) | 2009-09-21 | 2019-05-14 | Pocared Diagnostics Ltd. | System for conducting the identification of bacteria in biological samples |
| GB2477752A (en) * | 2010-02-11 | 2011-08-17 | Arab Biotechnology Company | Detection of bacteria |
| WO2014093463A1 (fr) | 2012-12-11 | 2014-06-19 | Pocared Diagnostics Ltd. | Cuvette optique à fond incurvé |
-
1979
- 1979-04-03 GB GB7911610A patent/GB2019563B/en not_active Expired
- 1979-04-12 IT IT21820/79A patent/IT1119718B/it active
- 1979-04-17 NL NL7902983A patent/NL7902983A/xx not_active Application Discontinuation
- 1979-04-18 DE DE19792915569 patent/DE2915569A1/de not_active Withdrawn
- 1979-04-19 BE BE0/194719A patent/BE875716A/fr not_active IP Right Cessation
- 1979-04-19 CA CA325,901A patent/CA1114271A/fr not_active Expired
- 1979-04-20 FR FR7910134A patent/FR2423784A1/fr active Granted
- 1979-04-20 CH CH377279A patent/CH641493A5/de not_active IP Right Cessation
- 1979-04-20 JP JP4888479A patent/JPS54149699A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| IT1119718B (it) | 1986-03-10 |
| JPS54149699A (en) | 1979-11-24 |
| IT7921820A0 (it) | 1979-04-12 |
| NL7902983A (nl) | 1979-10-23 |
| BE875716A (fr) | 1979-08-16 |
| GB2019563A (en) | 1979-10-31 |
| FR2423784A1 (fr) | 1979-11-16 |
| DE2915569A1 (de) | 1979-11-08 |
| CA1114271A (fr) | 1981-12-15 |
| GB2019563B (en) | 1982-07-28 |
| FR2423784B3 (fr) | 1982-02-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE2365629C2 (de) | Verfahren zur Herstellung von Limulina-Lysat oder dessen gefriergetrocknetem Pulver | |
| DE69432751T2 (de) | Präparation und stabilisation von zellen | |
| DE69603255T2 (de) | Verfahren zur modifizierung von oberflächen | |
| DE69504646T2 (de) | Herstellung und stabilisierung von zellsuspensionen | |
| DE69716064T2 (de) | Flüssigkeit zum sammeln von proben | |
| DD202178A5 (de) | Verfahren und reagens zur untersuchung von antigen-antikoerper-reaktionen | |
| DE2121994C3 (de) | Ermitteln der Empfindlichkeit von Bakterienstämmen auf antibiotische und/oder chemotherapeutische Mittel | |
| DE2248475B2 (de) | Verfahren zur gewinnung von hepatitissicheren, lagerungsstabilen und infundierbaren haemoglobinloesungen | |
| CH641493A5 (de) | Verfahren zur bestimmung von gram-negativen bakterien. | |
| DE2134928A1 (de) | Biologisches Reagens | |
| DE2602997C2 (de) | Lyophilisierte Kollagenzubereitung und Verfahren zu ihrer Herstellung | |
| DE69123445T2 (de) | Verfahren zur bestimmung von endotoxinen | |
| DE2951672C2 (fr) | ||
| DE2833545A1 (de) | Hochmolekulare meningokokken- gruppe c-vaccine und verfahren zu ihrer herstellung | |
| DE69731103T2 (de) | Verfahren zur proteinextraktion | |
| DE3151337A1 (de) | Blutkoagulationspromotor und verfahren zur beschleunigung der koagulation von gesamtblut | |
| DE602005003394T2 (de) | Verfahren zur Abtrennung und Inaktivierung von Virus- und Prionenkontaminationen | |
| DE3781279T2 (de) | Verfahren zur behandlung von blut. | |
| DE3404821A1 (de) | Verfahren zum nachweis von allergenhaltigem hausstaub | |
| DE3344607A1 (de) | Verfahren und zusammensetzung fuer die bestimmung der phagocytischen reaktion | |
| DE2412137A1 (de) | Praeparat zur verwendung bei blutuntersuchungsverfahren | |
| DE2038722A1 (de) | Verfahren zum Abtennen von Plasma oder Serum aus Blut | |
| DE2517860B2 (de) | Verfahren zum Bestimmen des Pyrogengehalts in Proben | |
| DE2353035B2 (de) | Verfahren zur Stabilisierung menschlicher oder tierischer Körperflüssigkeiten oder pflanzlicher Extrakte | |
| DE2429231A1 (de) | Diagnostikum fuer treponema-bakterien |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PL | Patent ceased | ||
| PL | Patent ceased |